Home › Funds › Boxer Capital Management, LLC › DFTX
Boxer Capital Management, LLC position in DFTX
DEFINIUM THERAPEUTICS INC · Health Care
Boxer Capital Management, LLC reported holding 998,500 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$47.0M, representing 3.54% of its reported portfolio and ranking #7 among its reported holdings. Boxer Capital Management, LLC has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's DFTX position evolved
Boxer Capital Management, LLC first disclosed a stake in DFTX in Q1 2026 at 598,500 shares (US$11.3M). The position peaked in Q2 2026 at 998,500 shares, worth US$47.0M. Across 2 filings, Boxer Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 998,500 shares valued at US$47.0M — an increase of 400,000 shares quarter over quarter.. Notable position changes include a 67% increase in Q2 2026 (shares fell 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 598.50K | $11.31M | New |
| Q2 2026 | 998.50K | $46.97M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DFTX and 13F data
DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 189 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$338.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$322.0M), Octagon Capital Advisors LP (US$138.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DFTX
- Avoro Capital Advisors LLC 7.19M sh · $338.17M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 6.85M sh · $322.00M · Q2 2026
- Octagon Capital Advisors LP 2.95M sh · $138.77M · Q2 2026
- Deep Track Capital, LP 2.75M sh · $129.36M · Q2 2026
- Commodore Capital LP 2.00M sh · $94.08M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.50M sh · $70.56M · Q2 2026
- Siren, L.L.C. 1.42M sh · $66.77M · Q2 2026
- AWM Investment Company, Inc. 784.80K sh · $36.92M · Q2 2026
- ArrowMark Colorado Holdings LLC 564.07K sh · $26.53M · Q2 2026
- Catalio Capital Management, LP 562.67K sh · $26.47M · Q2 2026
- Integral Health Asset Management, LLC 550.00K sh · $25.87M · Q2 2026
- GREAT POINT PARTNERS LLC 425.00K sh · $19.99M · Q2 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held DFTX?
Boxer Capital Management, LLC has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Boxer Capital Management, LLC's current position in DFTX?
As of Q2 2026, Boxer Capital Management, LLC holds 998.50K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $46.97M, representing 3.54% of its reported portfolio and ranking #7.
Has Boxer Capital Management, LLC been buying or selling DFTX?
In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC increased its position in DFTX. The position peaked in Q2 2026 at 998.50K shares.
Which other funds hold DFTX?
Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 189 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.